This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of bone and articular cartilage of limbs (controls excluding all cancers)
C3_BONE_CARTILAGE_LIMBS_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C40
Cause of death: ICD-9
170[4-5]|170[7-8]
Cause of death: ICD-8
170[4-5]|170[7-8]
Cancer registry: Topography ICD-O-3
C40
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
104
C3_BONE_CARTILAGE_LIMBS_EXALLC
Control definitions
Control exclude
C3_CANCER, C3_CANCER_WIDE
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of bone and articular cartilage of limbs (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of bone and articular cartilage of limbs
- Malignant neoplasm of bone and articular cartilage
- Malignant neoplasm of bone and articular cartilage (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 104 | 42 | 62 |
| Unadjusted prevalence (%) | 0.03 | 0.02 | 0.04 |
| Mean age at first event (years) | 39.57 | 39.13 | 39.86 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_BONE_CARTILAGE_LIMBS_EXALLC – Malignant neoplasm of bone and articular cartilage of limbs (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of bone and articular cartilage of limbs (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.